| FTFGX | OAYIX | FTFGX / OAYIX | |
| Total Expense Ratio | 0.74 | 0.89 | 83% |
| Annual Report Gross Expense Ratio | 0.78 | 0.89 | 88% |
| Fund Existence | 13 years | 10 years | - |
| Gain YTD | 11.135 | 5.401 | 206% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 100000 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.41B | 12.8B | 19% |
| Annual Yield % from dividends | 3.68 | 1.88 | 196% |
| Returns for 1 year | 18.23 | 11.63 | 157% |
| Returns for 3 years | 48.94 | 40.44 | 121% |
| Returns for 5 years | 55.79 | 30.60 | 182% |
| Returns for 10 years | 83.98 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NASDX | 52.85 | 0.47 | +0.90% |
| Shelton Nasdaq-100 Index Investor | |||
| ECHSX | 13.21 | N/A | N/A |
| Eaton Vance Worldwide Health Sci C | |||
| SVIIX | 10.48 | N/A | N/A |
| Virtus Ceredex Large-Cap Value Equity A | |||
| FCAGX | 38.20 | N/A | N/A |
| Fidelity Advisor Small Cap Growth A | |||
| ACMDX | 11.72 | N/A | N/A |
| Absolute Capital Defender Investor | |||